The company's SoftVue system is a whole breast ultrasound device that uses ring transducer and proprietary TriAD technology to differentiate between benign and malignant masses in breast cancer cases, providing a better patient experience without radiation or discomfort. SoftVue has received FDA clearance for diagnostic imaging, and Delphinus is committed to creating improved imaging methods to assist medical professionals in better defining and diagnosing breast disease for all women.